🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will use Prostate Specific Membrane Antigen (PSMA) and (18)F-Flu...
Status
Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2025-04-03
Trial ID
NCT06335914
Treatments Being Tested
This clinical trial studies multi-tracer positron emission tomography in pa...
Status
Terminated
Location
Huntsman Cancer Institute/University of Utah
Start Date
2011-02-02
Trial ID
NCT01243333
Treatments Being Tested
The objective of this protocol is to obtain a better match between the actu...
Status
Completed
Location
NAULT
Start Date
2020-07-17
Trial ID
NCT04391348
Treatments Being Tested
This phase I trial studies how well fluorine F 18 fluorthanatrace positron ...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2018-12-18
Trial ID
NCT03604315
The purpose of this study is to evaluate whether a semi-quantitative interp...
Status
Unknown
Location
Peking University Cancer Hospital
Start Date
2016-10
Trial ID
NCT02931201
Treatments Being Tested
RATIONALE: Diagnostic procedures, such as fludeoxyglucose F 18-PET imaging,...
Status
Completed
Location
Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
Start Date
2005-07
Trial ID
NCT00499395
Treatments Being Tested
This phase II trial studies how well fludeoxyglucose F-18 (18F-FDG) positro...
Status
Completed
Location
UCLA / Jonsson Comprehensive Cancer Center
Start Date
2018-11-28
Trial ID
NCT03732352
Treatments Being Tested
This phase II trial studies how well fludeoxyglucose F 18 (FDG)-labeled pos...
Status
Completed
Location
Harborview Medical Center
Start Date
2007-10
Trial ID
NCT00564733
This clinical trial studies how well fluorine F 18 fluorthanatrace (\[18F\]...
Status
Recruiting
Location
Fred Hutch/University of Washington Cancer Consortium
Start Date
2026-02-26
Trial ID
NCT06502691
This pilot phase I trial studies how well positron emission tomography (PET...
Status
Recruiting
Location
M D Anderson Cancer Center
Start Date
2020-07-15
Trial ID
NCT02390635